Back to search

Article

50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques

2016-05-17

Abstract excerpt

As the predominant etiological agent of the common cold, human rhinovirus (HRV) is the leading cause of human infectious disease. Early studies showed monovalent formalin-inactivated HRV vaccine can be protective, and virus-neutralizing antibodies (nAb) correlated with protection. However, co-circulation of many HRV types discouraged further vaccine efforts. We approached this problem straightforwardly. We tested...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22bbe9d7-694c-53b9-988e-bac7b8f9ff7e
DOI
10.1101/053967
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaquesDOI 10.1101/053967
Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid ProteinSemantic proximity
A rhinovirus vaccine evokes T cell mediated cross-reactive immunity in a preclinical model of rhinovirus infectionSemantic proximity
Induction of neutralising antibodies against conserved rhinovirus capsid protein VP4 depends on presenting VP4 in a virus-like conformationSemantic proximity
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical modelsSemantic proximity
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.Semantic proximity
Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus ChallengeSemantic proximity
A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice.Semantic proximity
Successful Vaccination Strategies That Protect Aged Mice from Lethal Challenge from Influenza Virus and Heterologous Severe Acute Respiratory Syndrome CoronavirusSemantic proximity
Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152Semantic proximity
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trialSemantic proximity
Antigen-dependent interplay of formulation, systemic innate responses, and antibody responses to multi-component replicon RNA vaccinationSemantic proximity
Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers.Semantic proximity
Select a neighboring publication to make it the new centre.